Microbiology & Infectious Diseases

The growing body of research on the gut-skin axis and human microbiome has sparked increasing interest in microbiome-modulatory agents as potential treatments for acne vulgaris.

Healthcare provider support for Lyme disease vaccination has declined since 2018, raising concerns about rollout readiness as the first vaccine nears approval.

Anal cancer screening in people with HIV (PWH) is entering a new era, following major advances in evidence and recent guideline updates that aim to reduce cancer burden in this high-risk group.

A national survey of Canadian long-term care homes found that most facilities are actively monitoring healthcare-associated infections (HAIs), antimicrobial-resistant organisms (AROs), and antibiotic use, though the consistency and scope of these efforts vary.

High-quality clinical data is essential to maintaining trust in influenza vaccination programs, especially as the global death toll from seasonal flu approaches 700,000 annually, disproportionately affecting older adults.

A new composite sampling method targeting the anterior nares and hands detects Candida auris colonization with greater accuracy and consistency than traditional screening sites, according to a prospective cohort study.

Implementing continuous laboratory automation significantly improves the management of bloodstream infections (BSIs), reducing diagnostic turnaround times and accelerating clinical decision-making, according to new data from a French ICU cohort.

Modulating the gut microbiome may enhance immunotherapy responses in patients with solid tumors, according to a recent review exploring emerging evidence across melanoma, renal cell carcinoma (RCC), and non-small cell lung cancer (NSCLC).